drugset
drugset / Trial / NCT05944848

A Study of CL-197 Capsules in Healthy Participants

NCT05944848 ↗

Phase 1 Completed 44 enrolled Henan Genuine Biotech Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetic characteristics of CL-197 capsules in health conditions.

Timeline

Start
2022-11-16
Primary completion
2024-01-20
Completion
2024-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject CL-197 Unknown 1 mg Oral
Subject CL-197 Unknown 10 mg Oral
Subject CL-197 Unknown 30 mg Oral
Subject CL-197 Unknown 60 mg Oral
Subject CL-197 Unknown 100 mg Oral

Indications

No indication recorded.